Impax Laboratories Inc.(NASDAQ: IPXL) today announced that the Company will present at the Cowen & Company 33rd Annual Health Care Conference on Wednesday March 6 at 8:00 a.m. Eastern Standard Time. The conference will be held at The Boston Marriott Copley Place Boston MA.
Individuals may listen to the live or an archived presentation made at the conference which will be posted in the investor relations section of the Companyâ€™s web site at www.impaxlabs.com. This presentation will be archived on the Companyâ€™s web site for 30 days.
About Impax Laboratories Inc.
Impax Laboratories Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally where strategically appropriate Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies such as injectables nasal sprays inhalers patches creams and ointments. Impax Laboratories is headquartered in Hayward California and has a full range of capabilities in its Hayward Philadelphia and Taiwan facilities. For more information please visit the Company's Web site at: www.impaxlabs.com.Business Wire
Last updated on: 01/03/2013